Qube Research & Technologies (QRT)’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,410
Closed -$808K 3553
2025
Q4
$808K Sell
33,410
-93,056
-74% -$2.43M ﹤0.01% 2640
2025
Q3
$3.23M Sell
126,466
-122,008
-49% -$2.89M ﹤0.01% 1999
2025
Q2
$5.35M Buy
248,474
+238,533
+2,399% +$5.38M 0.01% 1654
2025
Q1
$227K Buy
+9,941
New +$262K ﹤0.01% 2829
2022
Q3
Sell
-57,976
Closed -$801K 2523
2022
Q2
$801K Sell
57,976
-15,092
-21% -$221K 0.01% 1195
2022
Q1
$1.66M Buy
73,068
+49,735
+213% +$1.31M 0.01% 900
2021
Q4
$870K Buy
23,333
+8,083
+53% +$347K 0.01% 1279
2021
Q3
$645K Buy
+15,250
New +$734K 0.01% 1088
2021
Q2
Sell
-9,722
Closed -$350K 2279
2021
Q1
$350K Buy
+9,722
New +$384K 0.01% 1374

Other funds holding BLFS

Qube Research & Technologies (QRT)'s BLFS Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 33,410 shares — an estimated $808K sold.

Qube Research & Technologies (QRT) first reported a position in BLFS in Q1 2021 and held it in 9 quarters. The position peaked at $5.35M in Q2 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 33,410 BioLife Solutions shares in Q1 2026, an estimated $808K.
  • Qube Research & Technologies (QRT) first reported a position in BioLife Solutions in Q1 2021 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s BioLife Solutions position peaked at $5.35M in Q2 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.